(November 22, 2023, 11:22 AM EST) -- WASHINGTON, D.C. — A challenge by a drugmaker to a determination of unpatentability by the Patent Trial and Appeal Board that was issued after the statutory deadline to do so was rejected Nov. 21 by the Federal Circuit U.S. Court of Appeals, in what it deemed a matter of first impression....